Show simple item record

Article

dc.creatorRivera Romero, Octavioes
dc.creatorFaienza, Maria Feliciaes
dc.creatorVergani, Edoardoes
dc.creatorZucchiatti, Chantales
dc.creatorKoledova, Ekaterinaes
dc.date.accessioned2023-06-12T15:49:25Z
dc.date.available2023-06-12T15:49:25Z
dc.date.issued2023
dc.identifier.issn0926-9630es
dc.identifier.issn1879-8365es
dc.identifier.urihttps://hdl.handle.net/11441/147099
dc.description.abstractAdherence to recombinant human growth hormone (r-hGH; somatropin, [Saizen®], Merck Healthcare KGaA, Darmstadt, Germany) treatment is fundamental to achieve positive growth outcomes in children with growth disorders and to improve quality of life and cardiometabolic risk in adult patients affected by GH deficiency. Pen injector devices are commonly used to deliver r-hGH but, to the authors’ knowledge, none is currently digitally connected. Since digital health solutions are rapidly becoming valuable tools to support patients to adhere to treatment, the combination of a pen injector connected to a digital ecosystem to monitor treatment adherence is an important advance. Here, we present the methodology and first results of a participatory workshop that assessed clinicians’ perceptions on such a digital solution – the aluetta™ smartdot™ (Merck Healthcare KGaA, Darmstadt, Germany) – combining the aluetta™ pen injector and a connected device, components of a comprehensive digital health ecosystem to support pediatric patients receiving r-hGH treatment. The aim being to highlight the importance of collecting clinically meaningful and accurate real-world adherence data to support data-driven healthcare.es
dc.formatapplication/pdfes
dc.format.extent5 p.es
dc.language.isoenges
dc.publisherIOS Presses
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectAdherencees
dc.subjectConnected devicees
dc.subjectDigital ecosystemes
dc.subjectRecombinant human growth hormonees
dc.subjectParticipatory researches
dc.subjectPen injectores
dc.titleParticipatory Study to Explore Healthcare Professionals' Perceptions of a Connected Digital Solution for Adherence Monitoring of Recombinant Human Growth Hormone Treatment: Study Protocol and First Findingses
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Tecnología Electrónicaes
dc.relation.publisherversionhttps://ebooks.iospress.nl/doi/10.3233/SHTI230057es
dc.identifier.doi10.3233/SHTI230057es
dc.contributor.groupUniversidad de Sevilla. TIC150: Tecnología Electrónica e Informática Industriales
dc.journaltitleStudies in Health Technology and Informaticses
dc.publication.volumen302es
dc.publication.initialPage23es
dc.publication.endPage27es

FilesSizeFormatViewDescription
SHTI_rivera-romero_2023_partic ...372.5KbIcon   [PDF] View/Open  

This item appears in the following collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as: Attribution-NonCommercial-NoDerivatives 4.0 Internacional